242 related articles for article (PubMed ID: 37480146)
1. Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.
Feng D; Li L; Li D; Wu R; Zhu W; Wang J; Ye L; Han P
Eur J Med Res; 2023 Jul; 28(1):245. PubMed ID: 37480146
[TBL] [Abstract][Full Text] [Related]
2. Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.
Yang W; Wu X; Zhou F
Med Sci Monit; 2021 Feb; 27():e928919. PubMed ID: 33637669
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of hypoxia-inducible factor-1 alpha and prolyl 4-hydroxylase beta polypeptide overexpression in gastric cancer.
Zhang J; Wu Y; Lin YH; Guo S; Ning PF; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Jun; 24(22):2381-2391. PubMed ID: 29904245
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
[TBL] [Abstract][Full Text] [Related]
6. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-related gene
Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
[TBL] [Abstract][Full Text] [Related]
8. ARID1A loss induces P4HB to activate fibroblasts to support lung cancer cell growth, invasion, and chemoresistance.
Huang R; Wu D; Zhang K; Hu G; Liu Y; Jiang Y; Wang C; Zheng Y
Cancer Sci; 2024 Feb; 115(2):439-451. PubMed ID: 38100120
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis and bioinformatics analysis of P4HB expression levels in the prognosis of cancer patients.
Wang F; Yu Z; Liu X; Hu F; Liu X; Fu X; Liu Y; Zou Z
Pathol Res Pract; 2023 May; 245():154474. PubMed ID: 37119730
[TBL] [Abstract][Full Text] [Related]
10.
Zhang J; Guo S; Wu Y; Zheng ZC; Wang Y; Zhao Y
Biomed Res Int; 2019; 2019():9749751. PubMed ID: 31467922
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of P4HB is correlated with poor prognosis in human clear cell renal cell carcinoma.
Zhu Z; He A; Lv T; Xu C; Lin L; Lin J
Cancer Biomark; 2019; 26(4):431-439. PubMed ID: 31640086
[TBL] [Abstract][Full Text] [Related]
12. P4HB knockdown induces human HT29 colon cancer cell apoptosis through the generation of reactive oxygen species and inactivation of STAT3 signaling.
Zhou Y; Yang J; Zhang Q; Xu Q; Lu L; Wang J; Xia W
Mol Med Rep; 2019 Jan; 19(1):231-237. PubMed ID: 30431122
[TBL] [Abstract][Full Text] [Related]
13. Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients.
Feng D; Tuo Z; Wang J; Ye L; Li D; Wu R; Wei W; Yang Y; Zhang C
Heliyon; 2024 Jan; 10(1):e23495. PubMed ID: 38187257
[TBL] [Abstract][Full Text] [Related]
14. Regional assignment of the human gene coding for a multifunctional polypeptide (P4HB) acting as the beta-subunit of prolyl 4-hydroxylase and the enzyme protein disulfide isomerase to 17q25.
Pajunen L; Jones TA; Goddard A; Sheer D; Solomon E; Pihlajaniemi T; Kivirikko KI
Cytogenet Cell Genet; 1991; 56(3-4):165-8. PubMed ID: 1647289
[TBL] [Abstract][Full Text] [Related]
15. P4HB promotes HCC tumorigenesis through downregulation of GRP78 and subsequent upregulation of epithelial-to-mesenchymal transition.
Xia W; Zhuang J; Wang G; Ni J; Wang J; Ye Y
Oncotarget; 2017 Jan; 8(5):8512-8521. PubMed ID: 28052026
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
17.
Balasubramanian M; Padidela R; Pollitt RC; Bishop NJ; Mughal MZ; Offiah AC; Wagner BE; McCaughey J; Stephens DJ
J Med Genet; 2018 Mar; 55(3):158-165. PubMed ID: 29263160
[TBL] [Abstract][Full Text] [Related]
18. P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.
Wu Y; Peng Y; Guan B; He A; Yang K; He S; Gong Y; Li X; Zhou L
Oncol Lett; 2021 Feb; 21(2):95. PubMed ID: 33376528
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer.
Zheng L; Sun D; Fan W; Zhang Z; Li Q; Jiang T
PLoS One; 2015; 10(2):e0118276. PubMed ID: 25719802
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit α members in breast cancer.
Li M; Wang Q; Zheng Q; Wu L; Zhao B; Wu Y
Biomark Med; 2021 Sep; 15(13):1085-1095. PubMed ID: 34387118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
